ArticleJournal of thoracic disease2015

Chemotherapy versus tyrosine kinase inhibitor in EGFR unselected population advanced non-small cell lung cancer still matter of debate?-An update incorporating the DELTA trial data.

Marina C Garassino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.